TNFA
Price:
$5.2
Market Cap:
$9.18M
TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and ...[Read more]
Industry
Biotechnology
IPO Date
2014-01-23
Stock Exchange
NASDAQ
Ticker
TNFA
According to TNF Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -48.34%. This represents a change of 295.04% compared to the average of -12.24% of the last 4 quarters.
The mean historical ROE of TNF Pharmaceuticals, Inc. over the last ten years is -64.90%. The current -48.34% ROE has changed -25.52% with respect to the historical average. Over the past ten years (40 quarters), TNFA's ROE was at its highest in in the March 2020 quarter at 204.97%. The ROE was at its lowest in in the June 2024 quarter at -2502.18%.
Average
-64.90%
Median
-100.47%
Minimum
-185.97%
Maximum
334.42%
Discovering the peaks and valleys of TNF Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 567.73%
Maximum Annual ROE = 334.42%
Minimum Annual Increase = -904.62%
Minimum Annual ROE = -185.97%
| Year | ROE | Change |
|---|---|---|
| 2024 | -158.69% | 406.78% |
| 2023 | -31.31% | -69.72% |
| 2022 | -103.42% | -18.18% |
| 2021 | -126.40% | -137.80% |
| 2020 | 334.42% | -904.62% |
| 2019 | -41.56% | -77.65% |
| 2018 | -185.97% | 90.68% |
| 2017 | -97.53% | 0.01% |
| 2016 | -97.52% | -30.85% |
| 2015 | -141.02% | 567.73% |
The current ROE of TNF Pharmaceuticals, Inc. (TNFA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-97.81%
5-year avg
-17.08%
10-year avg
-64.90%
TNF Pharmaceuticals, Inc.’s ROE is less than Channel Therapeutics Corporation (243.75%), greater than CervoMed Inc. (-59.15%), greater than IMV Inc. (-489.29%), less than Apexigen, Inc. (48.27%), greater than Cyclacel Pharmaceuticals, Inc. (-187.31%), greater than COSCIENS Biopharma Inc. (-149.40%), greater than Tvardi Therapeutics, Inc. (-115.90%), greater than Turnstone Biologics Corp. (-171.86%), greater than Omega Therapeutics, Inc. (-173.25%), less than Biora Therapeutics, Inc. (12.18%),
| Company | ROE | Market cap |
|---|---|---|
| 243.75% | $8.90M | |
| -59.15% | $82.95M | |
| -489.29% | $117.00 | |
| 48.27% | $9.57M | |
| -187.31% | $10.61M | |
| -149.40% | $6.49M | |
| -115.90% | $40.34M | |
| -171.86% | $8.21M | |
| -173.25% | $7.90M | |
| 12.18% | $994.99K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TNF Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TNF Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TNF Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for TNF Pharmaceuticals, Inc. (TNFA)?
What is the highest ROE for TNF Pharmaceuticals, Inc. (TNFA)?
What is the 3-year average ROE for TNF Pharmaceuticals, Inc. (TNFA)?
What is the 5-year average ROE for TNF Pharmaceuticals, Inc. (TNFA)?
How does the current ROE for TNF Pharmaceuticals, Inc. (TNFA) compare to its historical average?